Click for best price
Connected Injectable Drug Delivery Devices Market Size, Share 2022
Market Analysis and Insights: Global Connected Injectable Drug Delivery Devices Market
The global Connected Injectable Drug Delivery Devices market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Connected Injectable Drug Delivery Devices market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Connected Injectable Drug Delivery Devices market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Connected Injectable Drug Delivery Devices market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Connected Injectable Drug Delivery Devices market.
Global Connected Injectable Drug Delivery Devices Scope and Market Size
Connected Injectable Drug Delivery Devices market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Connected Injectable Drug Delivery Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Connected Injectable Drug Delivery Devices market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Conventional Injection Devices
Self-Injection Devices
Others
Segment by Application
Diabetes
Cardiovascular Diseases
Autoimmune Diseases
Hormones Replacement
Neurology
Addiction
Respiratory Diseases
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Phillips-Medisize
West Pharmaceutical Services
Biocorp
Aterica
Unilife
Propeller Health
Haselmeier
SHL
Becton Dickinson
Baxter International
Scandinavian Health
Ypsomed
Terumo Medical
Schott
Owen Mumford
Antares Pharma
Zogenix
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Connected Injectable Drug Delivery Devices product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Connected Injectable Drug Delivery Devices, with price, sales, revenue, and global market share of Connected Injectable Drug Delivery Devices from 2019 to 2022.
Chapter 3, the Connected Injectable Drug Delivery Devices competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Connected Injectable Drug Delivery Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Connected Injectable Drug Delivery Devices market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Connected Injectable Drug Delivery Devices.
Chapter 13, 14, and 15, to describe Connected Injectable Drug Delivery Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Connected Injectable Drug Delivery Devices Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Connected Injectable Drug Delivery Devices Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
111 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Connected Injectable Drug Delivery Devices Product Introduction
1.2 Global Connected Injectable Drug Delivery Devices Outlook 2017 VS 2022 VS 2028
1.2.1 Global Connected Injectable Drug Delivery Devices Sales in US$ Million for the Year 2017-2028
1.2.2 Global Connected Injectable Drug Delivery Devices Sales in Volume for the Year 2017-2028
1.3 United States Connected Injectable Drug Delivery Devices Outlook 2017 VS 2022 VS 2028
1.3.1 United States Connected Injectable Drug Delivery Devices Sales in US$ Million for the Year 2017-2028
1.3.2 United States Connected Injectable Drug Delivery Devices Sales in Volume for the Year 2017-2028
1.4 Connected Injectable Drug Delivery Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Connected Injectable Drug Delivery Devices in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Connected Injectable Drug Delivery Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Connected Injectable Drug Delivery Devices Market Dynamics
1.5.1 Connected Injectable Drug Delivery Devices Industry Trends
1.5.2 Connected Injectable Drug Delivery Devices Market Drivers
1.5.3 Connected Injectable Drug Delivery Devices Market Challenges
1.5.4 Connected Injectable Drug Delivery Devices Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Connected Injectable Drug Delivery Devices Market Segment by Type
2.1.1 Conventional Injection Devices
2.1.2 Self-Injection Devices
2.1.3 Others
2.2 Global Connected Injectable Drug Delivery Devices Market Size by Type
2.2.1 Global Connected Injectable Drug Delivery Devices Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Connected Injectable Drug Delivery Devices Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Connected Injectable Drug Delivery Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Connected Injectable Drug Delivery Devices Market Size by Type
2.3.1 United States Connected Injectable Drug Delivery Devices Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Connected Injectable Drug Delivery Devices Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Connected Injectable Drug Delivery Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Connected Injectable Drug Delivery Devices Market Segment by Application
3.1.1 Diabetes
3.1.2 Cardiovascular Diseases
3.1.3 Autoimmune Diseases
3.1.4 Hormones Replacement
3.1.5 Neurology
3.1.6 Addiction
3.1.7 Respiratory Diseases
3.1.8 Others
3.2 Global Connected Injectable Drug Delivery Devices Market Size by Application
3.2.1 Global Connected Injectable Drug Delivery Devices Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Connected Injectable Drug Delivery Devices Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Connected Injectable Drug Delivery Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Connected Injectable Drug Delivery Devices Market Size by Application
3.3.1 United States Connected Injectable Drug Delivery Devices Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Connected Injectable Drug Delivery Devices Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Connected Injectable Drug Delivery Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Connected Injectable Drug Delivery Devices Competitor Landscape by Company
4.1 Global Connected Injectable Drug Delivery Devices Market Size by Company
4.1.1 Top Global Connected Injectable Drug Delivery Devices Manufacturers Ranked by Revenue (2021)
4.1.2 Global Connected Injectable Drug Delivery Devices Revenue by Manufacturer (2017-2022)
4.1.3 Global Connected Injectable Drug Delivery Devices Sales by Manufacturer (2017-2022)
4.1.4 Global Connected Injectable Drug Delivery Devices Price by Manufacturer (2017-2022)
4.2 Global Connected Injectable Drug Delivery Devices Concentration Ratio (CR)
4.2.1 Connected Injectable Drug Delivery Devices Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Connected Injectable Drug Delivery Devices in 2021
4.2.3 Global Connected Injectable Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Connected Injectable Drug Delivery Devices Manufacturing Base Distribution, Product Type
4.3.1 Global Connected Injectable Drug Delivery Devices Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Connected Injectable Drug Delivery Devices Product Type
4.3.3 Date of International Manufacturers Enter into Connected Injectable Drug Delivery Devices Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Connected Injectable Drug Delivery Devices Market Size by Company
4.5.1 Top Connected Injectable Drug Delivery Devices Players in United States, Ranked by Revenue (2021)
4.5.2 United States Connected Injectable Drug Delivery Devices Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Connected Injectable Drug Delivery Devices Sales by Players (2020, 2021 & 2022)
5 Global Connected Injectable Drug Delivery Devices Market Size by Region
5.1 Global Connected Injectable Drug Delivery Devices Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Connected Injectable Drug Delivery Devices Market Size in Volume by Region (2017-2028)
5.2.1 Global Connected Injectable Drug Delivery Devices Sales in Volume by Region: 2017-2022
5.2.2 Global Connected Injectable Drug Delivery Devices Sales in Volume Forecast by Region (2023-2028)
5.3 Global Connected Injectable Drug Delivery Devices Market Size in Value by Region (2017-2028)
5.3.1 Global Connected Injectable Drug Delivery Devices Sales in Value by Region: 2017-2022
5.3.2 Global Connected Injectable Drug Delivery Devices Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Connected Injectable Drug Delivery Devices Market Size YoY Growth 2017-2028
6.1.2 North America Connected Injectable Drug Delivery Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Connected Injectable Drug Delivery Devices Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Connected Injectable Drug Delivery Devices Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Connected Injectable Drug Delivery Devices Market Size YoY Growth 2017-2028
6.3.2 Europe Connected Injectable Drug Delivery Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Connected Injectable Drug Delivery Devices Market Size YoY Growth 2017-2028
6.4.2 Latin America Connected Injectable Drug Delivery Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Connected Injectable Drug Delivery Devices Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Connected Injectable Drug Delivery Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Phillips-Medisize
7.1.1 Phillips-Medisize Corporation Information
7.1.2 Phillips-Medisize Description and Business Overview
7.1.3 Phillips-Medisize Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Phillips-Medisize Connected Injectable Drug Delivery Devices Products Offered
7.1.5 Phillips-Medisize Recent Development
7.2 West Pharmaceutical Services
7.2.1 West Pharmaceutical Services Corporation Information
7.2.2 West Pharmaceutical Services Description and Business Overview
7.2.3 West Pharmaceutical Services Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.2.4 West Pharmaceutical Services Connected Injectable Drug Delivery Devices Products Offered
7.2.5 West Pharmaceutical Services Recent Development
7.3 Biocorp
7.3.1 Biocorp Corporation Information
7.3.2 Biocorp Description and Business Overview
7.3.3 Biocorp Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Biocorp Connected Injectable Drug Delivery Devices Products Offered
7.3.5 Biocorp Recent Development
7.4 Aterica
7.4.1 Aterica Corporation Information
7.4.2 Aterica Description and Business Overview
7.4.3 Aterica Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Aterica Connected Injectable Drug Delivery Devices Products Offered
7.4.5 Aterica Recent Development
7.5 Unilife
7.5.1 Unilife Corporation Information
7.5.2 Unilife Description and Business Overview
7.5.3 Unilife Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Unilife Connected Injectable Drug Delivery Devices Products Offered
7.5.5 Unilife Recent Development
7.6 Propeller Health
7.6.1 Propeller Health Corporation Information
7.6.2 Propeller Health Description and Business Overview
7.6.3 Propeller Health Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Propeller Health Connected Injectable Drug Delivery Devices Products Offered
7.6.5 Propeller Health Recent Development
7.7 Haselmeier
7.7.1 Haselmeier Corporation Information
7.7.2 Haselmeier Description and Business Overview
7.7.3 Haselmeier Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Haselmeier Connected Injectable Drug Delivery Devices Products Offered
7.7.5 Haselmeier Recent Development
7.8 SHL
7.8.1 SHL Corporation Information
7.8.2 SHL Description and Business Overview
7.8.3 SHL Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.8.4 SHL Connected Injectable Drug Delivery Devices Products Offered
7.8.5 SHL Recent Development
7.9 Becton Dickinson
7.9.1 Becton Dickinson Corporation Information
7.9.2 Becton Dickinson Description and Business Overview
7.9.3 Becton Dickinson Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Becton Dickinson Connected Injectable Drug Delivery Devices Products Offered
7.9.5 Becton Dickinson Recent Development
7.10 Baxter International
7.10.1 Baxter International Corporation Information
7.10.2 Baxter International Description and Business Overview
7.10.3 Baxter International Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Baxter International Connected Injectable Drug Delivery Devices Products Offered
7.10.5 Baxter International Recent Development
7.11 Scandinavian Health
7.11.1 Scandinavian Health Corporation Information
7.11.2 Scandinavian Health Description and Business Overview
7.11.3 Scandinavian Health Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Scandinavian Health Connected Injectable Drug Delivery Devices Products Offered
7.11.5 Scandinavian Health Recent Development
7.12 Ypsomed
7.12.1 Ypsomed Corporation Information
7.12.2 Ypsomed Description and Business Overview
7.12.3 Ypsomed Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Ypsomed Products Offered
7.12.5 Ypsomed Recent Development
7.13 Terumo Medical
7.13.1 Terumo Medical Corporation Information
7.13.2 Terumo Medical Description and Business Overview
7.13.3 Terumo Medical Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Terumo Medical Products Offered
7.13.5 Terumo Medical Recent Development
7.14 Schott
7.14.1 Schott Corporation Information
7.14.2 Schott Description and Business Overview
7.14.3 Schott Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Schott Products Offered
7.14.5 Schott Recent Development
7.15 Owen Mumford
7.15.1 Owen Mumford Corporation Information
7.15.2 Owen Mumford Description and Business Overview
7.15.3 Owen Mumford Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Owen Mumford Products Offered
7.15.5 Owen Mumford Recent Development
7.16 Antares Pharma
7.16.1 Antares Pharma Corporation Information
7.16.2 Antares Pharma Description and Business Overview
7.16.3 Antares Pharma Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Antares Pharma Products Offered
7.16.5 Antares Pharma Recent Development
7.17 Zogenix
7.17.1 Zogenix Corporation Information
7.17.2 Zogenix Description and Business Overview
7.17.3 Zogenix Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Zogenix Products Offered
7.17.5 Zogenix Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Connected Injectable Drug Delivery Devices Industry Chain Analysis
8.2 Connected Injectable Drug Delivery Devices Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Connected Injectable Drug Delivery Devices Distributors
8.3 Connected Injectable Drug Delivery Devices Production Mode & Process
8.4 Connected Injectable Drug Delivery Devices Sales and Marketing
8.4.1 Connected Injectable Drug Delivery Devices Sales Channels
8.4.2 Connected Injectable Drug Delivery Devices Distributors
8.5 Connected Injectable Drug Delivery Devices Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Connected Injectable Drug Delivery Devices CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Connected Injectable Drug Delivery Devices Market Trends
Table 3. Connected Injectable Drug Delivery Devices Market Drivers
Table 4. Connected Injectable Drug Delivery Devices Market Challenges
Table 5. Connected Injectable Drug Delivery Devices Market Restraints
Table 6. Global Connected Injectable Drug Delivery Devices Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Connected Injectable Drug Delivery Devices Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Connected Injectable Drug Delivery Devices Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Connected Injectable Drug Delivery Devices Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Connected Injectable Drug Delivery Devices Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Connected Injectable Drug Delivery Devices Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Connected Injectable Drug Delivery Devices Revenue Share by Manufacturer, 2017-2022
Table 13. Global Connected Injectable Drug Delivery Devices Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Connected Injectable Drug Delivery Devices Sales Share by Manufacturer, 2017-2022
Table 15. Global Connected Injectable Drug Delivery Devices Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Connected Injectable Drug Delivery Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Connected Injectable Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Connected Injectable Drug Delivery Devices as of 2021)
Table 18. Top Players of Connected Injectable Drug Delivery Devices in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Connected Injectable Drug Delivery Devices Product Type
Table 20. Date of International Manufacturers Enter into Connected Injectable Drug Delivery Devices Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Connected Injectable Drug Delivery Devices Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Connected Injectable Drug Delivery Devices Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Connected Injectable Drug Delivery Devices Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Connected Injectable Drug Delivery Devices Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Connected Injectable Drug Delivery Devices Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Connected Injectable Drug Delivery Devices Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Connected Injectable Drug Delivery Devices Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Connected Injectable Drug Delivery Devices Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Connected Injectable Drug Delivery Devices Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Connected Injectable Drug Delivery Devices Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Connected Injectable Drug Delivery Devices Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Connected Injectable Drug Delivery Devices Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Connected Injectable Drug Delivery Devices Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Connected Injectable Drug Delivery Devices Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Connected Injectable Drug Delivery Devices Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Connected Injectable Drug Delivery Devices Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Connected Injectable Drug Delivery Devices Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Connected Injectable Drug Delivery Devices Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Connected Injectable Drug Delivery Devices Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Connected Injectable Drug Delivery Devices Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Phillips-Medisize Corporation Information
Table 43. Phillips-Medisize Description and Business Overview
Table 44. Phillips-Medisize Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Phillips-Medisize Connected Injectable Drug Delivery Devices Product
Table 46. Phillips-Medisize Recent Development
Table 47. West Pharmaceutical Services Corporation Information
Table 48. West Pharmaceutical Services Description and Business Overview
Table 49. West Pharmaceutical Services Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. West Pharmaceutical Services Product
Table 51. West Pharmaceutical Services Recent Development
Table 52. Biocorp Corporation Information
Table 53. Biocorp Description and Business Overview
Table 54. Biocorp Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Biocorp Product
Table 56. Biocorp Recent Development
Table 57. Aterica Corporation Information
Table 58. Aterica Description and Business Overview
Table 59. Aterica Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Aterica Product
Table 61. Aterica Recent Development
Table 62. Unilife Corporation Information
Table 63. Unilife Description and Business Overview
Table 64. Unilife Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Unilife Product
Table 66. Unilife Recent Development
Table 67. Propeller Health Corporation Information
Table 68. Propeller Health Description and Business Overview
Table 69. Propeller Health Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Propeller Health Product
Table 71. Propeller Health Recent Development
Table 72. Haselmeier Corporation Information
Table 73. Haselmeier Description and Business Overview
Table 74. Haselmeier Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Haselmeier Product
Table 76. Haselmeier Recent Development
Table 77. SHL Corporation Information
Table 78. SHL Description and Business Overview
Table 79. SHL Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. SHL Product
Table 81. SHL Recent Development
Table 82. Becton Dickinson Corporation Information
Table 83. Becton Dickinson Description and Business Overview
Table 84. Becton Dickinson Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Becton Dickinson Product
Table 86. Becton Dickinson Recent Development
Table 87. Baxter International Corporation Information
Table 88. Baxter International Description and Business Overview
Table 89. Baxter International Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Baxter International Product
Table 91. Baxter International Recent Development
Table 92. Scandinavian Health Corporation Information
Table 93. Scandinavian Health Description and Business Overview
Table 94. Scandinavian Health Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. Scandinavian Health Product
Table 96. Scandinavian Health Recent Development
Table 97. Ypsomed Corporation Information
Table 98. Ypsomed Description and Business Overview
Table 99. Ypsomed Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 100. Ypsomed Product
Table 101. Ypsomed Recent Development
Table 102. Terumo Medical Corporation Information
Table 103. Terumo Medical Description and Business Overview
Table 104. Terumo Medical Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 105. Terumo Medical Product
Table 106. Terumo Medical Recent Development
Table 107. Schott Corporation Information
Table 108. Schott Description and Business Overview
Table 109. Schott Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Schott Product
Table 111. Schott Recent Development
Table 112. Owen Mumford Corporation Information
Table 113. Owen Mumford Description and Business Overview
Table 114. Owen Mumford Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. Owen Mumford Product
Table 116. Owen Mumford Recent Development
Table 117. Antares Pharma Corporation Information
Table 118. Antares Pharma Description and Business Overview
Table 119. Antares Pharma Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. Antares Pharma Product
Table 121. Antares Pharma Recent Development
Table 122. Zogenix Corporation Information
Table 123. Zogenix Description and Business Overview
Table 124. Zogenix Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Zogenix Product
Table 126. Zogenix Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Connected Injectable Drug Delivery Devices Customers List
Table 130. Connected Injectable Drug Delivery Devices Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Connected Injectable Drug Delivery Devices Product Picture
Figure 2. Global Connected Injectable Drug Delivery Devices Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Connected Injectable Drug Delivery Devices Market Size 2017-2028 (US$ Million)
Figure 4. Global Connected Injectable Drug Delivery Devices Sales 2017-2028 (K Units)
Figure 5. United States Connected Injectable Drug Delivery Devices Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Connected Injectable Drug Delivery Devices Market Size 2017-2028 (US$ Million)
Figure 7. United States Connected Injectable Drug Delivery Devices Sales 2017-2028 (K Units)
Figure 8. United States Connected Injectable Drug Delivery Devices Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Connected Injectable Drug Delivery Devices Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Connected Injectable Drug Delivery Devices Report Years Considered
Figure 11. Product Picture of Conventional Injection Devices
Figure 12. Product Picture of Self-Injection Devices
Figure 13. Product Picture of Others
Figure 14. Global Connected Injectable Drug Delivery Devices Market Share by Type in 2022 & 2028
Figure 15. Global Connected Injectable Drug Delivery Devices Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Connected Injectable Drug Delivery Devices Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Connected Injectable Drug Delivery Devices Sales by Type (2017-2028) & (K Units)
Figure 18. Global Connected Injectable Drug Delivery Devices Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Connected Injectable Drug Delivery Devices Price by Type (2017-2028) & (USD/Unit)
Figure 20. United States Connected Injectable Drug Delivery Devices Market Share by Type in 2022 & 2028
Figure 21. United States Connected Injectable Drug Delivery Devices Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Connected Injectable Drug Delivery Devices Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Connected Injectable Drug Delivery Devices Sales by Type (2017-2028) & (K Units)
Figure 24. United States Connected Injectable Drug Delivery Devices Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Connected Injectable Drug Delivery Devices Price by Type (2017-2028) & (USD/Unit)
Figure 26. Product Picture of Diabetes
Figure 27. Product Picture of Cardiovascular Diseases
Figure 28. Product Picture of Autoimmune Diseases
Figure 29. Product Picture of Hormones Replacement
Figure 30. Product Picture of Neurology
Figure 31. Product Picture of Addiction
Figure 32. Product Picture of Respiratory Diseases
Figure 33. Product Picture of Others
Figure 34. Global Connected Injectable Drug Delivery Devices Market Share by Application in 2022 & 2028
Figure 35. Global Connected Injectable Drug Delivery Devices Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. Global Connected Injectable Drug Delivery Devices Sales Market Share in Value by Application (2017-2028)
Figure 37. Global Connected Injectable Drug Delivery Devices Sales by Application (2017-2028) & (K Units)
Figure 38. Global Connected Injectable Drug Delivery Devices Sales Market Share in Volume by Application (2017-2028)
Figure 39. Global Connected Injectable Drug Delivery Devices Price by Application (2017-2028) & (USD/Unit)
Figure 40. United States Connected Injectable Drug Delivery Devices Market Share by Application in 2022 & 2028
Figure 41. United States Connected Injectable Drug Delivery Devices Sales in Value by Application (2017-2028) & (US$ Million)
Figure 42. United States Connected Injectable Drug Delivery Devices Sales Market Share in Value by Application (2017-2028)
Figure 43. United States Connected Injectable Drug Delivery Devices Sales by Application (2017-2028) & (K Units)
Figure 44. United States Connected Injectable Drug Delivery Devices Sales Market Share in Volume by Application (2017-2028)
Figure 45. United States Connected Injectable Drug Delivery Devices Price by Application (2017-2028) & (USD/Unit)
Figure 46. North America Connected Injectable Drug Delivery Devices Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 47. North America Connected Injectable Drug Delivery Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. U.S. Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Canada Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Europe Connected Injectable Drug Delivery Devices Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 51. Europe Connected Injectable Drug Delivery Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 52. Germany Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. France Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. U.K. Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Italy Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Russia Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Asia-Pacific Connected Injectable Drug Delivery Devices Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 58. Asia-Pacific Connected Injectable Drug Delivery Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 59. China Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Japan Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. South Korea Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. India Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Australia Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Taiwan Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Indonesia Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Thailand Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Malaysia Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Philippines Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Latin America Connected Injectable Drug Delivery Devices Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 70. Latin America Connected Injectable Drug Delivery Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Mexico Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Brazil Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Argentina Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Middle East & Africa Connected Injectable Drug Delivery Devices Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 75. Middle East & Africa Connected Injectable Drug Delivery Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 76. Turkey Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 77. Saudi Arabia Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 78. UAE Connected Injectable Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 79. Connected Injectable Drug Delivery Devices Value Chain
Figure 80. Connected Injectable Drug Delivery Devices Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
